Engineered Polypeptides Having Enhanced Duration Of Action

Patent No. EP2621538 (titled "Engineered Polypeptides Having Enhanced Duration Of Action") was filed by Amylin Pharmaceuticals on Sep 28, 2011. The application was issued on Dec 16, 2015.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
GENERICS UK	Sep 14, 2016	COOKE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

May 9, 2017
Communication to the parties concerning the termination of the opposition proceedings (opponent)
May 9, 2017
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
May 3, 2017
Termination of the opposition proceedings with revocation of patent
Feb 28, 2017
Advice of delivery
Jan 30, 2017
Advice of delivery
Jan 25, 2017
Advice of delivery
Jan 24, 2017
Acknowledgement of a document
Jan 24, 2017
Acknowledgement of a document
Jan 24, 2017
Brief communication - Opposition proceedings
Jan 24, 2017
Decision revoking the European patent
Jan 24, 2017
Decision revoking the European patent
Jan 16, 2017
(Electronic) Receipt
Jan 16, 2017
Letter accompanying subsequently filed items
Jan 16, 2017
Request for revocation of patent
Oct 26, 2016
Communication of a notice of opposition and request to file observations
Oct 26, 2016
Notice of further oppositions to opponent(s)
Oct 19, 2016
Brief communication - Opposition proceedings
Oct 18, 2016
Communication of amended entries
Oct 10, 2016
(Electronic) Receipt
Oct 10, 2016
Letter accompanying subsequently filed items
Oct 10, 2016
Request for a change of address - opponent
Sep 20, 2016
Communication of a notice of opposition - first information to patent proprietor
Sep 14, 2016
(Electronic) Receipt
Sep 14, 2016
Non-patent literature cited during the opposition procedure
Sep 14, 2016
Non-patent literature cited during the opposition procedure
Sep 14, 2016
Notice of opposition
Sep 14, 2016
Notice of opposition
Sep 14, 2016
Notice of opposition
Sep 14, 2016
Patent document cited during the opposition procedure
Sep 14, 2016
Patent document cited during the opposition procedure
Sep 14, 2016
Patent document cited during the opposition procedure
Dec 17, 2015
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Nov 19, 2015
Decision to grant a European patent
Oct 26, 2015
(Electronic) Receipt
Oct 26, 2015
Filing of the translations of the claims
Oct 26, 2015
French translation of claims
Oct 26, 2015
German translation of the claims
Oct 26, 2015
Letter accompanying subsequently filed items
Jun 17, 2015
Advice of delivery
Jun 16, 2015
Bibliographic data of the European patent application
Jun 16, 2015
Communication about intention to grant a European patent
Jun 16, 2015
Intention to grant (signatures)
Jun 16, 2015
Text intended for grant
Feb 13, 2015
(Electronic) Receipt
Feb 13, 2015
Amended description with annotations
Feb 13, 2015
Description
Feb 13, 2015
Letter accompanying subsequently filed items
Feb 13, 2015
Reply to communication from the Examining Division
Jan 21, 2015
Refund of fees
Jan 21, 2015
Refund of fees
Oct 9, 2014
Annex to the communication
Oct 9, 2014
Communication from the Examining Division
Sep 18, 2014
Examination started
May 16, 2014
Submission concerning representation
Jan 27, 2014
Communication to designated inventor
Jan 20, 2014
Notification of the recording of a change
Nov 18, 2013
Amended claims filed after receipt of (European) search report
Nov 18, 2013
Amended claims with annotations
Nov 18, 2013
Amendments received before examination
Nov 18, 2013
Non-patent literature cited during the examination procedure
Nov 18, 2013
Non-patent literature cited during the examination procedure
Nov 18, 2013
Payment of fees and costs
Jul 10, 2013
Notification on forthcoming publication of bibliographic data
May 8, 2013
Communication concerning correction of deficiencies in written opinion/amendment of application/payment of claims fee
May 6, 2013
Communication to designated inventor
May 6, 2013
Communication to designated inventor
May 6, 2013
Communication to designated inventor
May 6, 2013
Communication to designated inventor
May 6, 2013
Communication to designated inventor
May 6, 2013
Communication to designated inventor
May 6, 2013
Communication to designated inventor
May 6, 2013
Communication to designated inventor
May 6, 2013
Communication to designated inventor
May 6, 2013
Communication to designated inventor
Apr 16, 2013
(Electronic) Receipt
Apr 16, 2013
Request for entry into the European phase
Apr 15, 2013
Copy of the international preliminary report on patentability
Apr 10, 2013
Notification of the recording of a change
Apr 10, 2013
Notification of the recording of a change
Apr 10, 2013
Notification of the recording of a change
Apr 10, 2013
Notification of the recording of a change
Apr 10, 2013
Notification of the recording of a change
Apr 10, 2013
Notification of the recording of a change
Apr 10, 2013
Notification of the recording of a change
Apr 10, 2013
Notification of the recording of a change
Apr 10, 2013
Notification of the recording of a change
Apr 10, 2013
Notification of the recording of a change
Apr 10, 2013
Notification of the recording of a change
Apr 10, 2013
Notification of the recording of a change
Mar 28, 2013
Submission concerning representation
Feb 22, 2013
Information on entry into European phase
Jul 19, 2012
Copy of the international search report
Jul 19, 2012
International publication of the international search report
May 9, 2012
Priority document (electronically transmitted)
May 9, 2012
Priority document (electronically transmitted)
Apr 25, 2012
Written opinion of the ISA, boxes No. I to VIII
Apr 25, 2012
Written opinion of the ISA, cover sheet
Apr 25, 2012
Written opinion of the ISA, supplemental box
Apr 19, 2012
Converted Sequence Listing
Apr 19, 2012
Published international application - A2
Jan 12, 2012
Annex
Jan 12, 2012
Non-patent literature cited during the examination procedure
Jan 12, 2012
Submission concerning representation
Jan 11, 2012
Annex
Jan 11, 2012
Cover sheet for fax transmission
Jan 11, 2012
Non-patent literature cited during the examination procedure
Jan 11, 2012
Submission concerning representation
Oct 10, 2011
Abstract
Oct 10, 2011
Claims
Oct 10, 2011
Description
Oct 10, 2011
Drawings

EP2621538

AMYLIN PHARMACEUTICALS

Application Number: EP11767876A
Filing Date: Sep 28, 2011
Status: Revoked; Apr 15, 2019
Publication Date: Dec 16, 2015
External Links: Slate, Register , Google Patents

IP Verse

Engineered Polypeptides Having Enhanced Duration Of Action

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP2621538